CLINICAL CASE PROGRAM

LESIONS CAUSED BY THE HUMAN PAPILLOMA VIRUS

The Human Papillomavirus (HPV) is the most frequent sexually transmitted infection worldwide, affecting up to 90% of sexually active people. Although the vast majority of patients clear the infection spontaneously, viral persistence is related to the appearance of lesions of different nature and severity.

Procare Health, a pharmaceutical company committed to women’s health, has developed PAPILOCARE® vaginal gel, the first treatment indicated to prevent and treat low-grade cervical lesions caused by HPV, and PAPILOCARE® external genital gel, an adjuvant treatment for genital warts caused by HPV in men and women.

The program offers the opportunity to write up and submit a case collected during clinical practice in clinical work. The clinical cases received will be reviewed and evaluated by a committee of experts in Cervical Pathology formed by the following doctors:

Dr. Javier de Santiago

Head of Gynecologic Oncology Service. MD Anderson Cancer Center

Dr. Andrés Carlos López

Head of Obstetrics and Gynecology Service. Hospital Quirón salud Málaga

Dr. Juan Carlos Martínez Escoriza

Head of Obstetrics and Gynecology Service. General University Hospital Alicante

Dr. Javier Cortés

Former President of the Spanish Association of Cervical Pathology and Colposcopy (AEPCC).

The 1st edition of this program has been completed, the best clinical cases have been selected by the scientific committee and will have the opportunity to be presented in a virtual workshop by the author during the months of October and November 2021. In addition, the case “Condylomatosis vulvae. New local synergistic treatments” by Dr. Zuramis Estrada Blanco has been selected by the scientific committee as the best case and has been awarded the Dr. Eduardo Vilaplana prize, a pioneer in lower genital tract pathology and in the use of cytology in Spain, who recently passed away. The winning clinical case has been presented with a diploma and the award of a scholarship for registration in the next National Congress of the Oncology Section of the Spanish Society of Gynecology and Obstetrics.

 SELECTED CASES

Name

Surname

Name of the case

MARÍA

SERRANO VELASCO

Adjuvant treatment of vin with PAPILOCARE® External Gel. A case report

MARÍA

OTERO PARDO

Postconization cervical reepithelialization with Vaginal Gel based on Coriolus versicolor 

ESMERALDA
NATALIA

LÓPEZ
DEL VALLE SÁNCHEZ BAUDO LÓPEZ

Esthetic result after application of gel based on Coriolus versicolor as an adjuvant for epithelialization after simple vulvectomy by vinyl acetate.

NADIA

NASSAR MELIC

Use of Coriolus Versicolor vaginal gel in the conservative management of CIN 2.

JESÚS JOAQUÍN

HIJONA ELÓSEGUI

Efficacy of a Coriolus versicolor-based vaginal gel in HIV+ women with cervical lesions resulting from human papillomavirus infection.

ZURAMIS

ESTRADA BLANCO

Vulvar condylomatosis. New local synergistic treatments

FRANCISCA

GIL MEDINA

Lesiones escamosas intraepiteliales de cérvix de alto grado en tratamiento con Papilocare: evolución y pronóstico.

CARMEN BELÉN

DE LA TORRIENTE BENITO

High-grade squamous intraepithelial cervical lesions treated with Papilocare: evolution and prognosis.

CYNTHIA

MARTÍNEZ MARTÍNEZ

VAIN after hysterectomy for oncologic pathology 21 years ago

VANESA

RODRIGUEZ FERNANDEZ

Vaginal gel with Coriolus versicolor in the treatment of low-grade cervical dysplasia and persistent HPV after cevical conization in an HIV-positive woman: case report

 

2ND EDITION OF THE CLINICAL CASES PROGRAM IS NOW AVAILABLE.